- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
STAAR Surgical names Andrews as CFO
Monrovia, CA—STAAR Surgical Co. has named Deborah Andrews as its new chief financial officer (CFO), confirming a role she has filled on an interim basis since April.
Monrovia, CA-STAAR Surgical Co. has named Deborah Andrews as its new chief financial officer (CFO), confirming a role she has filled on an interim basis since April.
Andrews, who has been part of the firm's financial reporting team for more than 10 years, took on the role as CFO following the resignation of John Bily. She previously was the company's global controller.
In a prepared statement, company President and CEO David Bailey praised Andrews, 47, for improving STAAR's financial reporting and internal controls, and implementing cost-cutting strategies that reduced costs by $1.2 million during the second quarter of 2005 compared with the first quarter of 2005.
